Click it and Unblock the Notifications
Just In
Don't Miss
-
IPL Points Table 2024 After Today's Match, KKR vs RR: Check Indian Super League Standings And Results On April 16 -
UPSC Success Story: A Bombay IITian, A Government Job Holder at Railways, Quit the Job and Emerged as an IAS -
Kapil Sharma Reaches Vaishno Devi; Offers Prayers To The Shrine By Singing ‘Tune Mujhe Bulaya’, Watch -
Chaitra Navratri 2024: Your Sky Blue Ethnic Outfits Guide For Day 9 Look -
10 Bonus Shares, 1:2 & 1:5 Splits; Smallcap Steel Stock Below Rs 15, Falls 10% In 5 Days; Plans FPO Ahead -
Jeep Compass Gets More Powerful 268.3bhp Turbo Petrol Engine – Check Out All The Details Here -
Redmi Pad SE With 90Hz Display Launching on April 23 in India; Could Be Priced for Less Than Rs 20,000 -
From Coconut Breaking on Head to Men Dressing as Women: 12 Unique Indian Rituals Explored
AstraZeneca’s COVID-19 has reached phase 3 clinical trials in US
Washington, Sep 01: US President Donald Trump said that AstraZeneca's COVID-19 vaccine has reached phase 3 of clinical trials. It is very close to be finalised for approval.
"I am pleased to announce that AstraZeneca's vaccine has reached Phase 3 clinical trials and has joined various vaccines that are very close to the end. In the United States, we are doing things that people thought were not possible," Trump said at a press conference.
My administration did in a matter of months, Trump said, while adding that the process could have taken years to complete. AstraZeneca announced that its vaccine, developed by researchers at the Oxford University will enrol approximately 30,000 adult volunteers at 80 sites in the US.
AstraZeneca said in a statement, trial centres across the US are recruiting up to 30,000 adults aged 18 years or over from diverse racial, ethnic and geographic groups who are healthy or have stable underlying medical conditions, including those living with HIV, and who are at increased risk of infection from the SARS-CoV-2 virus.
